Muscle Relaxants, Central

• 

  Subject Areas on Research

  • 3-Halo-5,7-dimethylpyrazolo [1,5-a]pyrimidines, a nonbenzodiazepinoid class of antianxiety agents devoid of potentiation of central nervous system depressant effects of ethanol or barbiturates. 
  • Atypical neuroleptic malignant syndrome caused by clozapine and venlafaxine: early brief treatment with dantrolene. 
  • Baclofen Toxicity in Kidney Disease. 
  • CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease. 
  • Comparison of Tc99m-DTPA and indium-111 DTPA studies of baclofen pump function. 
  • Growth hormone response to baclofen: a comparison of 10-mg and 20-mg doses in healthy men. 
  • Intracranial hypotension from intrathecal baclofen pump insertion. A case report and review of the literature. 
  • Is it quinine TTP/HUS or quinine TMA? ADAMTS13 levels and implications for therapy. 
  • Pharmacological properties of tropyl benzilate hydrochloride (BAT) and its N-allyl derivative (NTB). 
  • Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn. 
  • Recognizing and treating malignant hyperthermia. 
  • Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. 
  • SPINAL OR GENERAL ANESTHESIA FOR INGUINAL HERNIA REPAIR?A COMPARISON OF CERTAIN COMPLICATIONS IN A CONTROLLED SERIES. 
  • The incidence of unacceptable movement with motor evoked potentials during craniotomy for aneurysm clipping. 
  • The persistence of electroconvulsive therapy-induced changes in the electroencephalogram. 
  • The use of analgesics in the management of pain in rheumatic diseases.